Schroder Investment Management Group Has $43.14 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Schroder Investment Management Group trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 3.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 623,707 shares of the company's stock after selling 21,295 shares during the quarter. Schroder Investment Management Group owned 0.50% of Henry Schein worth $43,142,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Henry Schein in the 4th quarter valued at $103,301,000. Holocene Advisors LP bought a new position in Henry Schein in the third quarter valued at about $58,319,000. Raymond James Financial Inc. bought a new position in Henry Schein in the fourth quarter valued at about $34,720,000. National Bank of Canada FI raised its stake in Henry Schein by 1,124.5% during the third quarter. National Bank of Canada FI now owns 535,950 shares of the company's stock worth $39,071,000 after acquiring an additional 492,181 shares in the last quarter. Finally, ING Groep NV lifted its holdings in shares of Henry Schein by 34.1% in the fourth quarter. ING Groep NV now owns 1,163,087 shares of the company's stock worth $80,486,000 after acquiring an additional 295,785 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on HSIC shares. Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective for the company. Barrington Research reiterated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Finally, Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $81.10.

Henry Schein Trading Down 1.7 %

Shares of Henry Schein stock traded down $1.12 during midday trading on Friday, reaching $65.47. The company had a trading volume of 2,362,489 shares, compared to its average volume of 1,585,938. The stock has a fifty day moving average price of $73.96 and a 200 day moving average price of $72.58. Henry Schein, Inc. has a fifty-two week low of $63.00 and a fifty-two week high of $82.49. The firm has a market cap of $8.13 billion, a PE ratio of 26.94, a P/E/G ratio of 2.13 and a beta of 0.84. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the firm posted $0.66 EPS. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. On average, equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.